A modest increase of GNP size from 5 to 13 nm in Gx-ManA leads to a markedly enhanced antiviral potency (e.g., ~19 and ~64 folds against DC-SIGN- and DC-SIGNR- mediated EBOVpp infection, respectively). Here, CD209 is linked to infection.